• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGENT; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGENT; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 3825
Device Problems Device Contamination with Chemical or Other Material (2944); Material Integrity Problem (2978)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/30/2022
Event Type  malfunction  
Event Description
It was reported that foreign material was noted on the device.A 2.00 mm x 15.00 mm agent drug coated balloon (dcb) was selected for treatment.Prior to entering the patient, foreign material was noticed on the drug coated part of the device.The drug coating was also reported to be non-uniform.An additional agent dcb was used to complete the procedure with no patient complications.
 
Event Description
It was reported that foreign material was noted on the device.A 2.00 mm x 15.00 mm agent drug coated balloon (dcb) was selected for treatment.Prior to entering the patient, foreign material was noticed on the drug coated part of the device.The drug coating was also reported to be non-uniform.An additional agent dcb was used to complete the procedure with no patient complications.
 
Manufacturer Narrative
Device evaluated by manufacturer: returned product consisted of an agent (dcb) balloon catheter.The device was visually and microscopically examined.There was no balloon protector or shipping mandrel returned with the device.There was no sign of fluids within the device.The balloon folds were intact with coating present.There was no damage or irregularities found to the device.Product analysis could not confirm the reported event as the condition of the coating showed no signs of damage or issue.Photo media analysis was provided and revealed that what is visible is part of the drug coating, which most likely is flaking off due to handling of the device.Otherwise, coating is okay.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGENT
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key15945978
MDR Text Key305176111
Report Number2124215-2022-51083
Device Sequence Number1
Product Code LOX
Combination Product (y/n)Y
Reporter Country CodeMY
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/26/2023
Device Model Number3825
Device Catalogue Number3825
Device Lot Number07526H21
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/13/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/26/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age48 YR
Patient SexMale
Patient Weight57 KG
Patient RaceAsian
-
-